Quick answer
This page lists 14 chemotherapy doctors in Hyderabad, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Chemotherapy doctors in Hyderabad, India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Chemotherapy doctors
FeaturedDr. Bharat Vaswani
MBBS, MD, DM, ECMO, MRCP-UK, PDCR
Clinical Director — Medical Oncology & Hematology · Specialty: Medical Oncologist & Hematologist
Yashoda Hospitals, Secunderabad Hyderabad, India26+ Years experience
Why consider this doctor?
- 26+ years of experience in Medical Oncologist & Hematologist
- Clinical Director — Medical Oncology & Hematology, Yashoda Hospitals, Secunderabad, Present
- Senior Consultant Medical Oncologist, SevenStar Hospital, Nagpur
Expertise & Procedures
- Chemotherapy Administration and Management
- Cancer Immunotherapy
- Targeted Molecular Therapy
- Hormone Therapy for Breast Cancer
- Hematological Malignancy Treatment
Medical Oncologist & Hematologist Experience: 26+ YearsHospital Affiliation: Yashoda Hospitals, SecunderabadHospital accreditation: NABH
Dr. Harish Kancharla
DM, MD, MBBS
Consultant — Medical Oncology and Hemato-Oncology · Specialty: Medical Oncologist and Hemato-Oncologist
Yashoda Hospitals Hyderabad, India14+ Years experience
Why consider this doctor?
- 14+ years of experience in Medical Oncologist and Hemato-Oncologist
- Consultant, Medical Oncology and Hemato-Oncology, Yashoda Hospitals, Hyderabad — Present
- Senior Resident/Fellow, Medical Oncology, AIIMS Delhi — 2017–2020
Expertise & Procedures
- Chemotherapy (conventional cytotoxic and targeted agents)
- Cancer immunotherapy and immune checkpoint inhibitor therapy
- Hormone therapy for breast and urogenital cancers
- Bone marrow transplantation and stem cell therapy
- Palliative care and symptom management
Medical Oncologist and Hemato-Oncologist Experience: 14+ YearsHospital Affiliation: Yashoda Hospitals
Dr. Macha Kiran Kumar
MBBS, MD, DM, ECMO, FCR, PDCR
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Secunderabad Hyderabad, India13+ Years experience
Why consider this doctor?
- 13+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology — Yashoda Hospitals, Secunderabad (Present)
- Consultant, Medical Oncology — Medicover Cancer Institute, Hitec City, Hyderabad
Expertise & Procedures
- Chemotherapy Administration and Management
- Cancer Immunotherapy and Checkpoint Inhibitors
- Targeted Molecular Therapy
- Hormone Therapy for Breast Cancer
- Autologous Stem Cell Transplantation
Medical Oncologist Experience: 13+ YearsHospital Affiliation: Yashoda Hospitals, SecunderabadHospital accreditation: NABH, NABL
Dr. Naidu N. Bethune
MBBS, MD, DM
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Hi-Tech City Hyderabad, India21+ Years experience
Why consider this doctor?
- 21+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Yashoda Hospitals, Hi-Tech City, Hyderabad (Present)
- Consultant — Medical Oncology, American Oncology Institute, Hyderabad
Expertise & Procedures
- Chemotherapy Administration for Solid and Hematological Cancers
- Targeted Therapy and Molecular Cancer Treatment
- Cancer Immunotherapy and Checkpoint Inhibitors
- Stem Cell Transplantation
- Bone Marrow Transplantation
Medical Oncologist Experience: 21+ YearsHospital Affiliation: Yashoda Hospitals, Hi-Tech CityHospital accreditation: NABH, NABL
Dr. Nikhil Suresh Ghadyalpatil
MBBS, MD, DM, MNAMS, DNB
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospital, Jubilee Hills Hyderabad, India18+ Years experience
Why consider this doctor?
- 18+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology, Apollo Hospital, Jubilee Hills, Hyderabad — Present
- Specialist in hemato-oncology and translational cancer research across leading Indian oncology centres
Expertise & Procedures
- Chemotherapy Administration for Solid Tumours
- Immunotherapy and Immune Checkpoint Inhibitor Therapy
- Molecular Targeted Therapy Planning
- Hormone Therapy for Breast and Prostate Cancer
- Adjuvant Chemotherapy Management
Medical Oncologist Experience: 18+ YearsHospital Affiliation: Apollo Hospital, Jubilee HillsHospital accreditation: JCI, NABH
Dr. Rekha Bansal
MBBS, DNB, DNB (Medical Oncology), DM (Medical Oncology)
Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospital, Jubilee Hills Hyderabad, India8+ Years experience
Why consider this doctor?
- 8+ years of experience in Medical Oncologist
- Consultant, Medical Oncology — Apollo Hospital, Jubilee Hills, Hyderabad (Present)
- Over 8 years of clinical experience in oncology and cancer management across tertiary care settings
Expertise & Procedures
- Adjuvant Chemotherapy for Solid Tumors
- Neoadjuvant Chemotherapy Planning
- Palliative Chemotherapy Management
- Immunotherapy with Checkpoint Inhibitors
- Molecular Targeted Therapy
Medical Oncologist Experience: 8+ YearsHospital Affiliation: Apollo Hospital, Jubilee HillsHospital accreditation: JCI, NABH
Dr. S V S S Prasad
MBBS, MD, DM
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospital, Jubilee Hills Hyderabad, India26+ Years experience
Why consider this doctor?
- 26+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology, Apollo Hospital Jubilee Hills, Hyderabad — Present
- 26+ years of clinical experience in medical oncology across government and private institutions
Expertise & Procedures
- Systemic chemotherapy planning and administration
- Immune checkpoint inhibitor therapy
- Targeted molecular therapy
- Hormone therapy for breast and gynecologic cancers
- Adjuvant and neoadjuvant chemotherapy
Medical Oncologist Experience: 26+ YearsHospital Affiliation: Apollo Hospital, Jubilee HillsHospital accreditation: JCI, NABH
Dr. Shikhar Kumar
MBBS, MD, DNB, DM, ECMO
Consultant Medical Oncologist · Specialty: Medical Oncologist
Yashoda Hospitals Hyderabad, India13+ Years experience
Why consider this doctor?
- 13+ years of experience in Medical Oncologist
- Consultant Medical Oncologist, Yashoda Hospitals, Hyderabad — Present
- Assistant Professor (Ad-Hoc), Tata Memorial Hospital, Mumbai — 2020–2021
Expertise & Procedures
- Chemotherapy administration and management
- Cancer immunotherapy and checkpoint inhibitor therapy
- Targeted cancer therapy
- Hormone therapy for breast and prostate cancer
- Hematologic malignancy treatment
Medical Oncologist Experience: 13+ YearsHospital Affiliation: Yashoda HospitalsHospital accreditation: NABH, NABL
Dr. Srinivas Chakravarthy G
MBBS, MD (General Medicine), DM Hematology, DM Medical Oncology, American Board Certified in Internal Medicine, American Board Certified in Hematology, American Board Certified in Medical Oncology
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Secunderabad Hyderabad, India26+ Years experience
Why consider this doctor?
- 26+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology, Yashoda Hospitals, Secunderabad, Hyderabad, India — Present
- Consultant Hematologist and Medical Oncologist, various leading hospitals in Hyderabad and USA — 26+ years
Expertise & Procedures
- Systemic Chemotherapy Administration
- Targeted Molecular Therapy
- Cancer Immunotherapy (CAR-T, Checkpoint Inhibitors)
- Hormone Therapy for Breast and Prostate Cancer
- Hematopoietic Stem Cell Transplantation
Medical Oncologist Experience: 26+ YearsHospital Affiliation: Yashoda Hospitals, SecunderabadHospital accreditation: NABH
Dr. Sudha Sinha
MBBS, American Board Certification in Internal Medicine, American Board Certification in Hematology, American Board Certification in Medical Oncology, ECFMG Certification
Clinical Director, HOD & Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospital Hyderabad, India23+ Years experience
Why consider this doctor?
- 23+ years of experience in Medical Oncologist
- Clinical Director, HOD, and Senior Consultant in Medical Oncology — Yashoda Hospital, Hyderabad, India (Present)
- Consultant Medical Oncologist — Care Hospitals, Hyderabad, India
Expertise & Procedures
- Chemotherapy Administration and Management
- CAR-T Cell Therapy
- Cancer Immunotherapy
- Targeted Therapy for Solid Tumors
- Hormone Therapy for Breast Cancer
Medical Oncologist Experience: 23+ YearsHospital Affiliation: Yashoda Hospital
Hospitals where these doctors practise
🇮🇳 Hitec City, Hyderabad, IndiaStarting from$1,000
Medicover Hospital Hitec City
Est. 2011
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
ChemotherapyMedical OncologyCardiac SurgeryCardiology
3+
Doctors for Chemotherapy
4.3
95 reviews
250+
Beds
15+
Years Since Founded
🇮🇳 Hyderabad, IndiaStarting from$1,000
Apollo Hospitals, Jubilee Hills
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ChemotherapyMedical OncologyCardiac SurgeryCardiology
5+
Doctors for Chemotherapy
4.1
44 reviews
550+
Beds
38+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for multiple myeloma treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Chemotherapy?
Chemotherapy is a systemic cancer treatment that uses potent drugs to destroy or slow the growth of cancer cells, either as a standalone treatment or combined with surgery and radiation therapy. It is typically administered in cycles over several weeks to months, tailored to the cancer type, stage, and patient's overall health. GAF Healthcare connects international patients with leading Indian oncology centers offering world-class chemotherapy protocols at a fraction of Western costs.
Who may be considered?
Chemotherapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Drugs are infused directly into the bloodstream through a vein, cannula, or implanted port, allowing systemic distribution throughout the body.
3 approaches available for this procedure:
Intravenous (IV) Chemotherapy
Most CommonDrugs are infused directly into the bloodstream through a vein, cannula, or implanted port, allowing systemic distribution throughout the body.
Comprehensive Investigations
Estimated cost: $200 - $600
CBC, liver and kidney function tests, tumor markers, CT/PET scan, ECG, echocardiogram (for cardiotoxic drugs), biopsy confirmation report
Treatment / Procedure Estimate
Estimated cost in India: $1,500 - $6,000
Stay in India
Pre-procedure stay (outside hospital): ~2 days
Hospitalisation: ~1 day per cycle (outpatient/day-care)
Recovery period (outside hospital): ~7-14 days between cycles
Total stay: approx 3-6 months (full treatment course)
Usually Included in Hospital Package
- Oncologist consultations
- Chemotherapy drugs (standard protocol)
- Day-care/nursing during infusion
- Pre-cycle blood monitoring
- Anti-nausea/supportive medications
Usually Not Included
- Targeted therapy or immunotherapy add-ons
- PICC line/port implantation surgery
- Hospitalization for complications
- Accommodation between cycles
- Travel and visa costs
Recovery and follow-up
Patients typically experience fatigue, nausea, and lowered immunity between cycles, requiring regular blood monitoring and supportive care; full recovery of energy levels may take several weeks after the final cycle. Long-term follow-up includes periodic scans and blood tests to monitor treatment response.
Risks
Common risks include nausea, hair loss, fatigue, low blood counts, and increased infection risk, while rare but serious risks include organ toxicity (heart, liver, or kidney) and severe allergic reactions. Regular monitoring helps detect and manage side effects early.
Alternatives
Depending on the cancer type and stage, alternatives or complements to chemotherapy may include surgery, radiation therapy, targeted therapy, immunotherapy, or hormone therapy. The best approach is determined by a multidisciplinary tumor board based on the patient's specific diagnosis.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Histopathology/biopsy report confirming cancer diagnosis
- CT/PET/MRI imaging reports
- Complete blood count (CBC) and metabolic panel
- Liver and kidney function test results
- Tumor marker test results
- ECG/echocardiogram report (if cardiotoxic drugs planned)
- Previous treatment summary (surgery, radiation, prior chemotherapy)
- List of current medications and allergies
Patient information needed
- Type, stage, and grade of cancer
- Age, weight, and general health status
- Comorbidities (diabetes, heart or kidney disease)
- Previous cancer treatments and response
- Current medications and known allergies
- Family history of cancer (if relevant)
- Preferred treatment duration and travel dates
- Availability of a caregiver during treatment
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Chemotherapy) and procedure (Chemotherapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Chemotherapy in Hyderabad, India
What is Multiple Myeloma?
Multiple myeloma is a cancer in which abnormal plasma cells accumulate in the bone marrow, producing excess proteins (called M-proteins or paraproteins) that can damage organs and disrupt normal blood cell production. It is considered a haematological malignancy and, while not currently curable in most cases, it is treatable and can often be managed effectively for many years.
What are the symptoms and health risks of Multiple Myeloma?
Common symptoms include persistent bone pain (particularly in the back, ribs, or hips), unexplained fatigue, frequent infections, easy bruising or bleeding, and signs of kidney problems such as increased thirst or reduced urine output. Some people experience numbness or weakness in the limbs if the disease affects the spine, and elevated calcium levels can cause confusion, nausea, or constipation. These symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis of multiple myeloma.
How is Multiple Myeloma diagnosed?
Diagnosis typically involves blood and urine tests to detect abnormal proteins (including serum protein electrophoresis, immunofixation, and free light chain assay), a full blood count, kidney and calcium level checks, and bone marrow biopsy to confirm the presence and proportion of malignant plasma cells. Imaging — such as whole-body low-dose CT, MRI, or PET-CT — is used to assess bone involvement and detect lesions. Disease severity is stratified using established staging systems such as the Revised International Staging System (R-ISS), which incorporates albumin, beta-2 microglobulin, LDH levels, and cytogenetic risk markers to guide prognosis and treatment decisions.
How is Multiple Myeloma treated?
Treatment is highly individualised and depends on factors including disease stage, cytogenetic risk profile, the patient's age, fitness, and organ function. For eligible patients, high-dose chemotherapy followed by autologous stem cell transplantation (using the patient's own stem cells) is a standard approach that can deepen and prolong remission. Alongside or instead of transplant, treatment may include combinations of targeted therapies (such as proteasome inhibitors or IMiDs), immunotherapy (including monoclonal antibodies), and conventional chemotherapy, with the specific regimen determined by a qualified specialist based on individual assessment.
Can Multiple Myeloma be treated without a procedure?
For patients who are not eligible for stem cell transplantation — due to age, fitness level, or other health conditions — effective non-procedural management is available using combinations of oral or intravenous targeted agents, immunotherapy, and chemotherapy. Supportive care measures, including bisphosphonates to protect bone health, growth factors to address anaemia, and prophylactic antibiotics to reduce infection risk, form an important part of ongoing management for all patients regardless of transplant eligibility. Active monitoring (sometimes called 'watch and wait') may be appropriate for asymptomatic precursor states such as smouldering myeloma, but this decision must be made by a specialist following careful individual assessment.
When is Chemotherapy considered for Multiple Myeloma?
Chemotherapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Multiple Myeloma?
Multiple myeloma is typically evaluated and managed by a haematologist or medical oncologist with specific expertise in haematological malignancies. For patients being considered for stem cell transplantation, care is coordinated through a specialist in bone marrow transplantation, usually within a multidisciplinary team that may also include nephrologists, radiologists, and specialist nurses.
How do I choose a doctor for Multiple Myeloma?
When selecting a specialist or facility, it is worth asking about the centre's volume and experience specifically in treating multiple myeloma, whether they offer access to a full multidisciplinary team, availability of novel and clinical-trial therapies, and what structured follow-up and relapse monitoring looks like over the long term.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.